The September 2026 mistrial in Lindsay Clancy’s first-degree murder case—ending 11-1 for acquittal by reason of insanity—remains the dominant factor behind traders’ 94.8% implied probability against a manslaughter conviction this year. With prosecutors still undecided on retrying the 2023 deaths of her three children and defense motions pending a November 2 hearing, any new trial faces clear scheduling hurdles, including defense counsel’s unavailability before mid-2027. Court records confirm Clancy stays committed at Tewksbury Hospital without a verdict. While a plea to manslaughter or accelerated retrial could theoretically shift the outcome, the current procedural timeline and jury deadlock strongly support the market consensus that no conviction will occur before year-end.